Biotech | September 10, 2025
Evonik and Ethris partner to expand offerings for nucleic acid delivery
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
The transaction enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide
The plant will have installed production capacity of 3,120 MT/month
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Increases speed to market for drug developers working on nucleic acid therapeutics
Subscribe To Our Newsletter & Stay Updated
